What They List
- Psilocybin Clinical Trial
- Study Screening Information
- Research Participation Details
Research
NCT07063862 - Psilocybin Microdose for Psychological and Existential Distress in Palliative Care (PSYCHED-PAL-RCT)
Clinical Trial in Brampton, Ontario
About 30-50% of patients with advanced illness experience depression, anxiety, or decreased sense of purpose and autonomy. Together, these are called psychological distress. Treatment options such as medication and therapy are available; however, they do not always work and can be time-consuming and expensive. We need treatments that work well, quickly, and can be available to all patients with advanced illness wh... Source record lists lead sponsor Bruyère Health Research Institute. and overall status Recruiting.
Clinical TrialResearch
Directory Facts
- Status
- Verified from official/source records
- Price
- Free study screening / research participation
- Hours
- Verify with provider
- License / Record
- NCT07063862
- Last Verified
- 2026-06-12
Location
William Osler Health System, Brampton, Ontario
Source Notes
Discovery row generated from the official ClinicalTrials.gov API record for NCT07063862; status Recruiting; sponsor Bruyère Health Research Institute..
Source: https://clinicaltrials.gov/study/NCT07063862
MagicMushroomsDirectory does not provide medical, legal, or purchasing advice. Verify current laws, provider status, and eligibility before contacting any listing.